Cannabis

Cannabis lobbying surged 60% — the fastest growth of any industry. DEA rescheduling to Schedule III would be transformative, opening banking access and eliminating the punitive 280E tax. The industry is professionalizing rapidly, hiring former government officials and building DC infrastructure. But the fundamental contradiction — legal in half the states, federally illegal — creates lobbying challenges that no other industry faces.

$8.0M spent lobbying Washington in 2024 (+60% vs 2023)

Lobbying (2024)

$8.0M

Political Spending

$5.0M

Lobbyists

40

Revolving Door

10

personnel

🏭 The Cannabis Money Machine

The fastest-growing lobby by percentage (60% YOY) but still small in absolute terms. Cannabis is legal in 24 states but remains federally illegal, creating a bizarre regulatory environment where legal businesses can't access banking. The SAFE Banking Act has bipartisan support but keeps stalling. The industry is desperate for legitimacy and spends accordingly.

The cannabis industry spent $8.0M lobbying Washington in 2024, up 60% from $5.0M in 2023. With 40 registered lobbyists working the halls of Congress, this is an industry that takes its political influence seriously. Beyond lobbying, the industry poured an additional $5.0M into direct political spending — campaign contributions, PAC donations, and independent expenditures designed to shape who holds power.

The industry's top spenders include US Cannabis Council, National Cannabis Industry Association, Various MSOs (multi-state operators). These companies and organizations don't spend millions on lobbying out of civic duty — each dollar is a calculated investment in regulatory outcomes, tax treatment, and government contracts that directly affect their bottom lines. The concentration of spending among a handful of top players reveals an industry where political influence is as important as market competition.

The industry's lobbying efforts center on , , . Each of these issues represents a potential shift in the regulatory landscape that could mean billions in gains or losses for the companies involved. When the stakes are this high, political spending isn't an expense — it's an investment with measurable returns.

With 10 former government officials now working for cannabiscompanies or lobbying firms, the revolving door between Washington and industry spins freely. These former regulators, congressional staffers, and agency officials bring with them not just expertise but relationships — the kind of access and insider knowledge that money alone can't buy. It's the most effective form of influence: putting people who wrote the rules on the payroll of companies those rules are meant to govern.

📊 Lobbying Trend

2023

$5.0M

2024

$8.0M

Change

+60%

2023
2024

🏢 Top Spenders

The companies and organizations spending the most to influence policy. These are the players shaping the cannabis regulatory landscape.

1.US Cannabis Council
2.National Cannabis Industry Association
3.Various MSOs (multi-state operators)

📌 Key Issues & Industry Position

What the cannabis industry is fighting for — and against. Each issue represents a policy battle where lobbying dollars are deployed to shape outcomes.

Support rescheduling to Schedule III$3.0M
Strongly support$2.0M
Eliminate punitive tax on cannabis businesses$1.5M
Support$500K

🏛️ Regulatory Bodies

The government agencies tasked with regulating this industry. The revolving door between these bodies and the companies they oversee is a critical part of the influence story.

DEA

FDA

Treasury (FinCEN)

IRS